# Belimumab

## Benlysta inj 400mg

| TAH Drug Code      | [IBEN](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IBEN)                                                                                                                                                                                                                                                                                                                               |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | In combination with standard treatment， indicated for patients aged 5 years and older with autoimmune antibody-positive systemic lupus erythematosus (SLE) who still exhibit high disease activity under standard treatment (e.g.， positive anti-dsDNA， low complement， SELENA SLEDAI ? 8). In combination with standard treatment， indicated for adult patients with active lupus nephritis. |
| Dosing             | IVD， 10 mg/kg over 1 hour every 2 weeks for the first 3 doses and every 4 weeks thereafter.                                                                                                                                                                                                                                                                                                       |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                      |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                      |
| Contraindications  | Hypersensitivity.                                                                                                                                                                                                                                                                                                                                                                                  |
| Adverse Effects    | Infections. Hypersensitivity reaction; pyrexia， infusion-related reaction.                                                                                                                                                                                                                                                                                                                        |
| Pregnancy          | Human (and Animal) Data Suggest Risk                                                                                                                                                                                                                                                                                                                                                               |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                      |
| More Info          | [UpToDate](https://www.uptodate.com/contents/belimumab-drug-information)                                                                                                                                                                                                                                                                                                                           |

